Important information on storage and handling of JYNNEOS vaccine
On September 24, 2019, the U.S. Food and Drug Administration (FDA) approved the first live, non-replicating vaccine for prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection.
While there is currently no vaccine available from the manufacturer for use, the Department of Defense and other government partners are engaged in robust discussions regarding future deployment of this vaccine within the military.
Further information will be provided once available.
You are leaving Health.mil
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil
View the external links disclaimer.
Last Updated: July 11, 2022